Clinical trial Recruiting at 1 site Interventional Ages 22 to 65

TMS plus Emotion Regulation Skills Training for Borderline Personality Disorder

Official title: Combining Transcranial Magnetic Stimulation With Emotion Regulation Skills Training in Borderline Personality Disorder

Run by Massachusetts General Hospital · NCT07714005 · Data updated 2026-11-12

This study tests whether adding transcranial magnetic stimulation to emotion regulation skills training helps people with borderline personality disorder improve their ability to manage emotions.

Quick facts

Study typeInterventional
Ages22 Years to 65 Years
SexAll
Enrollment12 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedSeptember 1, 2027
Study endsDecember 1, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07714005 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 22-65 with DSM-5 confirmed BPD and clinically significant emotion dysregulation (DERS ≥ 80).

Probably not a fit

Individuals with active suicidality, recent substance use disorder, psychosis history, or contraindications to TMS/MRI may be less likely to benefit or participate.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study combines transcranial magnetic stimulation (TMS) with targeted emotion regulation skills training for adults diagnosed with borderline personality disorder. The approach aims to enhance neurocircuitry support for emotion regulation while teaching practical skills to reduce dysregulated emotional responses. Participants will have DSM-5–confirmed BPD, elevated emotion dysregulation, and stable medical management, with safety screenings and MRI/TMS contraindication checks. The trial uses established behavioral ER training alongside neuromodulation to explore potential synergistic effects on emotional control and related functioning.

Why it matters

Potential benefit: If successful, participants may experience better emotion regulation, fewer self-harm urges, and improvements in mood stability and daily functioning.

How similar studies have gone: Prior emotion regulation training and neuromodulation approaches have shown promise in related disorders, with mixed results in BPD, making this combination exploratory yet promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* DSM-5 diagnosis of borderline personality disorder;
* Clinical levels of emotion dysregulation as determined by a score ≥ 80 on the DERS;
* Male and female sex as assigned at birth;
* ages 22-65;
* able to provide informed consent and provide verifiable contact information;
* stable medication regimen.

Exclusion Criteria:

* current active suicidality (suicidal ideation with intent or plan)
* current substance use disorder for the past 6 months (substance use disorder in remission permitted);
* history of psychosis;
* dementia or other major neurological disorders
* medical illness or non-psychiatric medical treatment that would likely interfere with study participation;
* contraindications for MRI or TMS, including the presence of metallic implants that would interfere with safety (i.e. cardiac pacemaker, metal plates, non-removable body piercings, etc.), history of seizure disorder, history of head trauma;
* a clinical course of a neuromodulatory therapy (e.g. TMS, tDCS, ECT) within the past 6 months;
* current use of benzodiazepines (can interfere with iTBS stimulation);
* current pregnancy, to limit potential risks to an unborn child;
* concurrent participation in cognitive behavioral therapy (CBT) or dialectical behavioral therapy (DBT) during participation ER-skills training portion of study.
* non-English speaking (ER skills training delivered in English only)

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Kristen K Ellard, Ph.D. — Massachusetts General Hospital
  • Study coordinator: Kristen K Ellard, Ph.D.
  • Email: kellard@mgh.harvard.edu
  • Phone: 617-724-3221

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.